Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200215046504N1
IRCT20200215046504N1
Completed
未知

Functional Outcomes of Botulinum Neurotoxin-A Injection Followed by Reciprocal Electrical Stimulation of Upper-Limb Muscles in Children with Cerebral Palsy

Prince Sattam bin Abdulaziz University/Deanship of Scientific Research0 sites56 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Prince Sattam bin Abdulaziz University/Deanship of Scientific Research
Enrollment
56
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Prince Sattam bin Abdulaziz University/Deanship of Scientific Research

Eligibility Criteria

Inclusion Criteria

  • •Diagnosis of spastic hemiplegic cerebral palsy
  • •age between 6 and 10 years
  • •Spasticity grade II or III according to Modified Ashworth Scale
  • •mental capacity enabling compliance with evaluation and treatment instructions
  • •Normal/corrected visual and auditory function

Exclusion Criteria

  • •Contractures limiting arm\-hand function
  • •Botulinum toxin\-A injection in the involved upper limb in the past six months
  • •If children will be advised against stopping spasticity\-relieving medications during the study period by their neuro\-pediatrician
  • •Orthopedic or neuromuscular surgery or casting of the paretic upper limb within 1 year before starting study
  • •Uncontrolled seizures

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Influence of Botulinum Toxin A injections into the calf muscles on the recurvation of the knee joint in patients with spastic infantile cerebral palsyG80.0Q66.0Spastic quadriplegic cerebral palsyTalipes equinovarus
DRKS00022883niversitätsklinik HeidelbergKlinik für Orthopädie und Unfallchirurgie20
Recruiting
Phase 2
Botulinum Toxin Type A with Needle-free Injector System in Palmar HyperhidrosisPalmar hyperhidrosis
JPRN-jRCTs041180067Ohshima Yuichiro25
Active, not recruiting
Not Applicable
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.
EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166
NL-OMON39359Revalidatiecentrum Het Roessingh26
Completed
Phase 2
Botulinum toxin for nocturnal bruxism.
ACTRN12618001430224Melbourne Health41